|
RP Acquires Vision AI Firm, CT Lung Screening, and Pre-RSNA News
November 20, 2025
|
|
|
|
|
Together with
|
|
|
|
“Special-purpose radiology VLMs are the next leap; they create reports directly from images and cases. This is clearly the direction for radiology AI image analysis and diagnosis.”
|
|
Amine Korchi, MD, on Radiology Partners’ acquisition of Cognita Imaging.
|
|
|
New solutions are becoming available for lung ventilation/perfusion (V/Q) analysis, which can help clinicians detect problems with lung function. In this episode of The Imaging Wire Show, we talk to Greg Mogel, MD, of 4DMedical and Trishul Siddharthan, MD, of the University of Miami on how these solutions can change patient management.
|
|
|
|
Radiology Partners ramped up its investment in AI by acquiring Cognita Imaging, a startup that’s developed AI vision language models for analyzing CT and X-ray images and drafting initial radiology reports. RP executives see the acquisition as going beyond traditional point-source AI models and toward a future where AI automates much of the traditional image interpretation process.
The $80M acquisition expands on an equity stake RP already had in Cognita, which had been operating in stealth mode since its spin-off from Stanford University’s Center for Artificial Intelligence in Medicine and Imaging lab.
- Cognita was formed by a team led by CEO Louis Blankemeier, PhD, to commercialize Stanford research on vision language models, a type of generative AI that’s far more versatile than the traditional point-source models being commercialized to analyze medical images.
Instead, Cognita’s technology is able to analyze text as well as CT or X-ray images and produce first drafts of radiology reports that just need a radiologist’s review and signature to be complete.
- Extremely positive clinical tests with Cognita’s VLM models spurred RP to acquire the rest of the company it didn’t already own, said Rich Whitney, chairman and CEO of Radiology Partners.
Cognita’s technology powers Mosaic Drafting, RP’s new application for helping radiologists draft reports that operates under the company’s recently launched Mosaic Clinical Technologies branding. Early clinical testing has found that Mosaic Drafting…
- Increases radiologist detection rates by 52%.
- Results in a fourfold decline in radiologist errors.
- Reduces radiologist reading times by up to 76%.
RP plans to deploy Mosaic Drafting through Mosaic Clinical Technologies, which the company launched in July as the technological foundation for a massive rollout of AI across its physician practices.
- Mosaic Chief Medical AI Officer Nina Kottler, MD, said Mosaic Drafting is currently being used within Radiology Partners under IRB approval, but the company will pursue an FDA authorization – most likely under a de novo pathway – that probably will come sometime in 2026.
In a broader sense, RP sees Mosaic Drafting and other VLM tools as key to the growing mismatch between rising imaging volume and stagnant radiologist supply – a mismatch that can only be solved through greater automation.
- And as the largest private radiology organization in the U.S., Radiology Partners has the organizational heft to make VLMs work on a wide scale.
The Takeaway
RP’s acquisition of Cognita is a major development in putting vision language models on the fast track to real-world clinical use. Unlike point-source AI, VLMs could hold the key to really solving radiology’s volume overload dilemma.
|
|
Reshaping the Future of Medical Imaging
Get ready for an unforgettable experience at RSNA 2025, where United Imaging will unveil major innovations that can reshape the future of medical imaging. Visit them at booth #1929 to see their comprehensive multimodality portfolio.
|
|
Optimize Radiology Workflows
Harness cloud and AI technology to help your radiology teams unlock insights, increase efficiencies, and improve patient care. Learn more about an integrated approach to AI in radiology in this e-book from Microsoft.
|
|
Meet Merge at RSNA 2025
From first click to final read, Merge accelerates your workflows with imaging solutions designed by people who think like you. Book a meeting at RSNA 2025 booth #6100 to get your own live demonstration.
|
|
- Lung Screening Momentum Builds: A new research letter in JAMA underscores the growing momentum – and life-saving potential – of CT lung cancer screening. Researchers calculated screening compliance from a sample of 2.1k screening-eligible people from the NHIS survey, finding 19% were up-to-date with screening recommendations. If extrapolated to the rest of the U.S., this level of screening compliance would save 15k lives and gain 190k life-years over five years. At 100% compliance, lung screening would save 62k lives and 872k life-years among screening-eligible people.
- Risk-Based Lung Screening More Efficient: As Germany prepares to implement large-scale CT lung cancer screening, a new study suggests its NELSON-based screening criteria using age and smoking history might not be the best. The HANSE study in The Lancet Oncology found that PLCOm2012’s six-year risk criteria were more efficient than NELSON criteria in detecting cancer in 5.1k individuals (2.59% vs. 2.17%) and therefore had a lower number of people needed to screen to find one cancer (39 vs. 46).
- Low-Intensity Smokers at Higher Risk: Meanwhile, a new study on the health risks of low-intensity smoking could prompt debate over whether established lung cancer screening guidelines should be expanded. In a meta-analysis in PLOS Medicine of nearly two dozen studies covering 300k people, even very low-intensity smoking was associated with a 50% higher risk of heart failure and 60% higher all-cause mortality compared to never smoking. Former smokers still had higher risk up to three decades after quitting.
- AI Improves Lung Nodule Stratification: RevealDx’s AI-based lung nodule stratification tool enabled U.K. clinicians to better stratify suspicious nodules found on CT scans in a new study in Clinical Radiology. Researchers used RevealAI-Lung to retrospectively analyze images from 200 patients with an equal number of benign and malignant nodules. Of those with malignant nodules, AI would have upgraded 44% of cases, reducing delayed diagnoses from 45% to 25%. Of benign cases, 7% would have been downgraded to no follow-up, and 7% to immediate follow-up PET/CT.
- Philips Expands Cortechs Partnership: Philips expanded its partnership with Cortechs.ai to integrate that company’s NeuroQuant AI-based solutions for neuroimaging analysis directly into Philips MRI scanners. The new integration enables clinicians to get AI-generated quantitative reports within their MRI or PACS workstation without creating extra steps for technologists. NeuroQuant has already been available on Philips’ Advanced Visualization Workspace.
- Screening AI Finds More Breast Cancers: Most of the large studies showing AI’s benefit for breast cancer screening were performed in Europe, but a new large-scale trial also shows positive results with U.S. mammography workflow. The ASSURE study in Nature Health included 579k women and tested AI from RadNet subsidiary DeepHealth as a safeguard that triggered a second radiologist review for suspicious cases. AI analysis led to a 22% boost in cancer detection rate per 1k women (5.6 vs. 4.6 cancers).
- Ikonopedia Reports Risk Aware Growth: Ikonopedia is reporting 40% growth in adoption of its Risk Aware tool for calculating breast cancer risk. The software calculates a woman’s risk of breast cancer based on Tyrer-Cuzick criteria, and since it was launched in 2023, it’s been adopted by over 50 healthcare organizations, with 40% growth in Q3 2025 compared to a year ago. Evaluating women with tools like Risk Aware enables radiologists to identify patients who might benefit from additional surveillance like MRI, genetic screening, or early mammography.
- CCTA Reveals Hypertension’s Early Risk: Adolescents with high blood pressure had higher rates of atherosclerosis on coronary CT angiography scans some 40 years later. In a new study in JAMA Cardiology, researchers studied 10.2k Swedish military conscripts who got blood pressure readings at about 20 years old. CCTA exams were performed at a median age of 58, finding that those with stage 2 hypertension in adolescence had 84% higher odds of severe coronary stenosis in middle age, as well as higher stenosis prevalence (10.1% vs. 6.9%).
- Mindray Expands Handheld Ultrasound Line: Mindray is expanding its line of handheld point-of-care ultrasound scanners with the launch of TE Air e5M, a POCUS unit designed for whole-body scanning. The new unit joins TE Air i3P in the company’s TE Air wireless ultrasound portfolio and is designed to be used in multiple care settings, including primary and acute care, remote medicine, and education. It supports 22 exam types and features up to 120 minutes of battery life.
- Siemens Reorg Separates Diagnostics: Siemens Healthineers laid the groundwork for a spinoff of its lab diagnostics business with a reorganization announced this week. The company said the Diagnostics division would “pursue its own strategy, enabled by its own set-up,” and in a press briefing CEO Bernd Montag said it was possible Diagnostics would not be part of the medical group by 2030. Among other changes, the company is forming a new Precision Therapy division to include its Varian radiation oncology unit along with advanced therapies and ultrasound.
- Siemens Rebrands Radiopharma Units: In other Siemens Healthineers news, the company has rebranded its PETNET Solutions and Advanced Accelerator Applications Molecular Imaging subsidiaries as Siemens Healthineers, with each unit’s operations reporting under the Radiopharma business segment. Siemens acquired AAA from Novartis in 2024 and — along with PETNET — the Radiopharma business operates 60 radiopharmacy facilities in nine countries, producing 100k batches of PET radiopharmaceuticals a year.
- Visage Scores $29M Contract: Visage Imaging signed a contract worth $29M to install its Visage 7 enterprise imaging software at Advanced Radiology Management, a U.S. private-practice remote radiology group. Visage will install its cloud-based software including Visage Viewer to provide a single unified enterprise imaging platform for the group, with go-live targeted for Q2 2026. In other Visage news, the company is highlighting its upcoming appearance at RSNA 2025, including a demonstration of the Apple Vision Pro headset in radiology.
- RapidAI’s Aortic AI Clearance: RapidAI received FDA clearance for an AI algorithm for detecting and managing aortic aneurysms. Called Aortic Management, the solution analyzes CT scans that include the aorta and produces 3D reconstructions that help radiologists assess the aorta and track anatomical changes over time. The algorithm is built on RapidAI’s Rapid Enterprise platform and is available on the company’s cloud-based platform.
- Fujifilm Launches Synapse One: Fujifilm Healthcare Americas introduced Synapse One, a software package designed to meet all the image management needs of outpatient imaging centers. Synapse One’s features include PACS, RIS, scheduling, revenue cycle management, physician portal, and patient engagement, and the entire package runs on the AWS cloud. Fujifilm believes that consolidating multiple IT solutions into a single system will reduce operational costs and complexity for centers by eliminating third-party software integrations.
- Lumexa Files for $200M IPO: Lumexa Imaging – the radiology chain formerly known as U.S. Radiology Specialists – has filed documents for an IPO worth an expected $200M. In SEC documents, Lumexa claims to be the second largest outpatient imaging center firm in the U.S., with 184 centers in 13 states (RadNet has 405 in eight states). Lumexa’s revenue for the nine months to date is $755.3M (+7.8%) with a net loss for the period of $18.4M. Lumexa adopted its new branding earlier this year.
- Qure Cements Microsoft Alliance: Qure.ai’s AI algorithms for detecting lung cancer will be made available through Microsoft’s Precision Imaging Network platform under a new alliance between the companies. Qure’s AI solutions can either be deployed through PIN as individual products or collectively as a suite, and include applications like qXR-LN for X-ray nodule detection, qCT-LN Quant for CT measurement and quantification, and qTrack for coordinating patient management.
- Gradient Gets Google Boost: Gradient Health’s Atlas AI data aggregation platform is now available on Google Cloud Marketplace, making it easier for AI developers to access de-identified data for training algorithms. Atlas includes data from millions of medical imaging studies across different modalities, pathologies, and patient types, enabling foundation model developers to train and test models with real-world data.
|
|
Abdominal Ultrasound Worksheets and Reports in 45 Seconds
Visit Kailo Medical at booth #4555 at RSNA 2025 to discover augmented reporting that produces worksheets and reports in 45 seconds, improving accuracy, boosting efficiency, and delivering better outcomes for patients and providers alike.
|
|
Reimagine Imaging Innovation
Experience a new era of diagnostic imaging in the AGFA HealthCare booth #2565 at RSNA 2025 in which every click, case, and connection is designed around how you work. Request an on-site demo today.
|
|
- Book a Demo with CARPL at RSNA 2025: CARPL helps healthcare providers realize the value of the entire AI ecosystem and drive financial, operational, and clinical ROI. Book a demo today or visit them at RSNA 2025 booth #5732.
- Connect Every Pixel to the Patient Story: Mach7 Technologies is soaring above silos at RSNA 2025 with an imaging architecture that unifies your data, takes your EMR to new heights, and transforms images into insights. See how with a demo at booth #3351.
- Interpretation Efficiency in Radiology – A Critical Strategy: Healthcare institutions are at a critical stage, where an emphasis on interpretation efficiency needs to be a priority. Check out this white paper from Visage Imaging and Signify Research on strategies to optimize your interpretation efficiency.
- Experience the Future of Radiology: Visit Enlitic at RSNA 2025 booth #7730 to experience the future of radiology and see how the company is revolutionizing radiology data migration with its Laitek acquisition. Schedule a meeting today.
- Transforming Chest Imaging at RSNA 2025: Learn how solutions from Riverain Technologies like its ClearRead AI technology are transforming chest imaging. Visit them at booth #4711 or schedule your meeting today.
- What Would You Do with an Extra Hour? Rad AI Impressions automatically generates your report impressions in your own voice, from your dictated findings. Radiology teams already use Rad AI to give radiologists their time back. See what you could do with yours. Book your RSNA meeting today.
- Discover What’s Next in Radiology at RSNA 2025: Join Philips at RSNA 2025 in booth #6730 to see revolutionary new innovations in MRI, CT, and informatics. Don’t miss your chance to witness breakthroughs that will redefine what’s possible at 10:30 am on Sunday November 30.
- It’s Time to Make AI Adoption Simple: Visit Gleamer at RSNA 2025 booth #4936 to experience a milestone moment that will reshape AI’s role in medical imaging. Expect more than a sneak peak: Expect the future.
- Every Image Tells a Story at RSNA 2025: Visit Intelerad at RSNA 2025 booth #6113 to learn how their solutions are empowering radiologists and patients while transforming radiology workflows. Schedule a meeting today.
- Building the Future of Radiology: Visit Medality at RSNA 2025 booth #1140 to learn how they are at the forefront of radiology practice growth and training as the simulated learning platform that everyone loves. Book a demo today.
- Advanced AI for Prostate MRI: QP-Prostate from Quibim is your advanced solution for detection and diagnosis of prostate cancer from MRI scans. Discover how it streamlines your workflow by detecting suspicious lesions, segmenting the prostate, and ensuring compliance with PI-RADS V2.1 guidelines.
- A New Standard of AI-Powered Care: Visit DeepHealth at RSNA 2025 booth #1329 to learn how their integrated, cloud-native solutions can unify your imaging experience. Book a meeting today.
- AI Handheld Echo for Preoperative Assessment: Read this overview of an ASE 2025 paper on the feasibility of handheld echo equipped with Us2.ai software for assessing left ventricular diastolic dysfunction in preoperative patients and how it compared to cart-based systems.
- The Future of Fluoroscopy Is Here: The future of fluoroscopy has arrived. The LUMINOS Q.namix fluoroscopy systems from Siemens Healthineers are available on the U.S. market. Discover why they have already earned the prestigious Red Dot Design Award for intuitive design and user-centric innovation.
- Radiology Case Report: A man in his 50s presented with syncope with minor head trauma and unassociated risk factors. Find out how MRI helped provide a diagnosis in this case study.
|
|
|
|
|
